SfN18: The potential of gene therapy in neurological disorders

Written by Sharon Salt, Editor

Promising findings from preclinical animal studies presented at SfN Neuroscience (3–7 November, San Diego, CA, USA) show the potential of gene therapy in slowing down disease progression, and improving symptoms, in neurological disorders such as amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD). Although gene therapy is a promising treatment option for a limited number of conditions, the technique is still experimental for most diseases, with ongoing research to ensure they will be safe and effective in human patients. New technique allows gene therapy to be delivered to the spinal cord in mice A new technique for gene therapy can...

To view the full article, please register now for access

It's completely free